Menu

The Precision Medicine Revolution: CRISPR-Based Therapies

The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps for those looking to adopt the technique. 

Sep 7, 2017
The Scientist Creative Services Team

The Precision Medicine Revolution: CRISPR-Based Therapies from thescientistllc on Vimeo.

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene-editing technology has been hailed as a breakthrough and emerged as the new face of precision medicine. Its potential as a treatment for numerous diseases, stretching from various cancer types to neurological diseases to lethal heritable disorders, has been well documented. However, efforts are ongoing that aim to clarify the complex issues surrounding the legality and ethics of genome editing for human use. For a detailed look at the progress made toward CRISPR-mediated correction of human diseases and the continuing ethics debate, The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps for those looking to adopt the technique. Attendees will have the opportunity to interact with experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • CRISPR-generated model systems for in vivo study of a wide range of diseases
  • Therapeutic applications of genome editing and their associated societal implications

Register Now

Meet the Speakers:

Dana Carroll, PhD
Distinguished Professor, Department of Biochemistry
University of Utah School of Medicine

 

 

James Dahlman, PhD
Assistant Professor, Department of Biomedical Engineering
Georgia Institute of Technology and Emory School of Medicine

 

 




 
 

 

 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.